List of Genetic Tests and Analyses : FISH днк дослідження, тромбофілія і аналіз хромосом та ін.
 
 
Навчальні програми

List of Genetic Tests and Analyses

bt_bb_section_bottom_section_coverage_image
Quality of Life Improvement
  • 0051    Lactose Intolerance (Genetic testing), (2 days)
  • 0058    Celiac Disease (Genetic predisposition), (6 days)
  • 0060    Interleukin IL-28B (Genotyping), (6 days)
  • 0061    Telomere Length Analysis, (6 days)
  • 0062    Apolipoprotein E (ApoE) Genotyping (Alzheimer’s disease risk), (6 days)
  • 0063    Nutrigenetics (Nutrition & Diet genetics), (10 days)
  • 0064    Nutrigenetics + ApoE , (10 days)
  • 0072    Atopic Dermatitis & Psoriasis Predisposition, (6 days)
  • 0075    Multidrug Resistance (MDR1, (6 days)
  • 0094    Folate Metabolism: MTHFR, (6 days)
  • 0095    Folate Metabolism: MTR & MTRR, (6 days)
  • 0096    Folate Metabolism Panel (MTHFR, MTR, MTRR), (6 days)
  • 0097    Detoxification System Genes (GSTP1, GSTM1, GSTT1), (6 days)
  • 0117    ACE Gene (Angiotensin-Converting Enzyme), (6 days)
Autoimmune Diseases. Genetic Predisposition to Autoimmune Diseases
  • 0052 HLA B-27, (2 days)
  • 0053 HLA B-7, (2 days)
  • 0054 HLA B-27 and HLA B-7, (2 days)
  • 0058 Celiac Disease, (6 days)
  • 0087 Familial Mediterranean Fever (FMF). Periodic Disease, (6 days)
Sequencing

  • 0351 Sanger Sequencing, (3 months)

    Any gene or gene region can be selected for sequencing. Can be used as an additional analysis for family testing.

International Referral Testing
  • Sequencing panels Invitae, (3 months)
  • Genome/exome sequencing 3billion, (3 months)
Oncology and Oncogenetics
  • 0055 Hereditary Breast and Ovarian Cancer Susceptibility, BRCA1 and BRCA2 Gene Mutations, (6 days)
  • 0056 Hereditary Breast and Ovarian Cancer Susceptibility Panel, BRCA1 and BRCA2 (8 mutations), (6 days)
  • 0059 Crohn’s Disease Susceptibility, (6 days)
  • 0074 JAK2 V617F Mutation, (7 days)
  • 0103 Oncology Genetic Panel, (10 days)
  • 0116 Nijmegen Breakage Syndrome, (10 days)
  • 0600 BRAF Gene Mutations (Tumor Tissue), (7 days)
  • 0601 BCR-ABL1 Translocation t(9;22)(q34;q11.2), p210, PCR (Qualitative), (5 days)
  • 0602 BCR-ABL1 Translocation t(9;22)(q34;q11.2), p210, PCR (Quantitative), (5 days)
  • 0206 BCR-ABL1 Translocation t(9;22), FISH Method, (16 days)
  • 0603 MPL W515A-L-K-R Mutations, PCR (Qualitative), (10 days)
  • 0205 Oncohematological Diseases. Bone Marrow Karyotyping (GTG-banding), (15 days)
  • 0205.1 Oncohematological Diseases. Peripheral Blood Karyotyping (GTG-banding), (15 days)
Monogenic Disorders
  • 0089 Achondroplasia / Hypochondroplasia, (7 days)
  • 0066 Wilson’s Disease, (6 days)
  • 0090 Galactosemia, (7 days)
  • 0088 Duchenne/Becker Muscular Dystrophy, (10 days)
  • 0088.1 Duchenne/Becker Muscular Dystrophy. MLPA, (12 days)
  • 0081 Cystic Fibrosis Panel 1, (8 days)
  • 0082 Cystic Fibrosis Panel 2, (12 days)
  • 0083 Cystic Fibrosis Panel 3 (Expanded), (15 days)
  • 0091 Sensorineural Hearing Loss/Deafness, (10 days)
  • 0116 Nijmegen Breakage Syndrome, (10 days)
  • 0087 Familial Mediterranean Fever (FMF), (10 days)
  • 0065 Hereditary Hemochromatosis, (6 days)
  • 0084 Spinal Muscular Atrophy (SMA), (8 days)
  • 0084.1 SMA Heterozygous Carrier Screening, (8 days)
  • 0085 Spinal Muscular Atrophy (SMA). SMN Gene Copy Number Analysis, (10 days)
  • 0086 Phenylketonuria (PKU), (10 days)
  • 0086.1 Phenylketonuria (PKU). Expanded Panel, (10 days)
  • 0400 Fragile X Syndrome (FRAX). Martin-Bell Syndrome, (10 days)
  • 0059 Crohn’s Disease, (6 days)
  • 0119 Kennedy Disease (Spinal Bulbar Muscular Atrophy), (7 days)
Hepatobiliary Disorders
  • 0060 Interleukin-28B (IL28B) Polymorphism, (6 days)
  • 0065 Hereditary Hemochromatosis, (6 days)
  • 0066 Wilson’s Disease, (6 days)
  • 0067 Gilbert’s Syndrome, (8 days)
  • 0068 Comprehensive Liver Disease Panel (Hepatobiliary Panel). Genetic Factors of Hepatitis, (12 days)
  • 0069 Comprehensive Liver Disease Panel + Alpha-1 Antitrypsin Deficiency, (12 days)
  • 0070 Alpha-1 Antitrypsin Deficiency (Chronic Respiratory Pathology, Hepatopathy), (6 days)
  • 0122 LCHAD Deficiency (Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency), (7 days)
Infertility and Reproductive Dysfunction
  • 0081 Cystic Fibrosis Panel 1, (8 days)
  • 0093 Y-Chromosome AZF Microdeletions. SRY Gene Detection, (6 days)
  • 0108 Sperm DNA Fragmentation Analysis, (2 days)
  • 0109 Semen Analysis and Sperm DNA Fragmentation, (2 days)
  • 0110 Sperm FISH (Fluorescence In Situ Hybridization), (10 days)
  • 0076 Hereditary Thrombophilic Factors, (6 days)
  • 0076.1 Factor V Leiden (FVL) Mutation, (6 days)
  • 0076.2 Prothrombin G20210A (Factor II) Mutation, (6 days)
  • 0077 (0104) Hereditary Thrombophilic Factors. Recurrent Pregnancy Loss, (6 days)
  • 0078 Hereditary Thrombophilic Factors. Expanded Panel, (6 days)
  • 0098 HLA Class II Genotyping: DQA1 and DRB1 Loci, (12 days)
  • 0099 HLA Class II Genotyping: DRB1, DQA1, and DQB1 Loci, (12 days)
  • 0100 HLA Class II Genotyping: DQB1 Locus, (6 days)
  • 0122 LCHAD Deficiency (Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency), (7 days)
  • 0111 Products of Conception (POC) Testing by FISH. Aneuploidy Screening for Chromosomes 13, 14, 15, 16, 17, 18, 20, 21, 22, X, and Y, (12 days)
  • 0400 Fragile X Syndrome (FRAX). Martin-Bell Syndrome, (10 days)
Genetic Panels
  • 0068 Comprehensive Liver Disease Panel (Hepatobiliary Panel). Genetic Factors of Hepatitis, (12 days)
  • 0069 Comprehensive Liver Disease Panel + Alpha-1 Antitrypsin Deficiency, (12 days)
  • 0077 (0104) Hereditary Thrombophilic Factors. Recurrent Pregnancy Loss, (6 days)
  • 0078 Hereditary Thrombophilic Factors. Expanded Panel, (6 days)
  • 0103 Oncology Genetic Panel, (10 days)
  • 0104 Pregnancy Planning Panel. Heterozygous Carrier Screening. Genetics (Female), (12 days)
  • 0106 Pregnancy Planning Panel. Genetics (Couple), (12 days)
  • 0314 31 Microdeletion Syndromes. MULTI Microdeletion Syndromes Panel, (10 days)
  • 0315 ALL-chromosome. Subtelomeric Regions Detection for All Chromosomes, (10 days)
Syndromes
  • 0314 31 Microdeletion Syndromes. MULTI Microdeletion Syndromes Panel, (10 days)
  • 0315 ALL-chromosome. Subtelomeric Regions Detection for All Chromosomes, (10 days)
  • 0317 Adrenogenital Syndrome (Congenital Adrenal Hyperplasia). MLPA, (10 days)
  • 0311 Angelman Syndrome (from 31 MS Panel), (10 days)
  • 0319 Angelman Syndrome. Methylation Analysis, (10 days)
  • 0115.4 Angelman Syndrome. FISH Method, (10 days)
  • 0115.6 X-Chromosome Copy Number Analysis, (10 days)
  • 0313 Beckwith-Wiedemann Syndrome, (10 days)
  • 0308 Williams Syndrome (from 31 MS Panel), (10 days)
  • 0115.7 Williams Syndrome (Williams-Beuren). FISH Method, (10 days)
  • 0307 Wolf-Hirschhorn Syndrome (from 31 MS Panel), (10 days)
  • 0115.2 Wolf-Hirschhorn Syndrome. FISH Method, (10 days)
  • 0115.8 Down Syndrome (Trisomy 21) / Patau Syndrome (Trisomy 13). FISH Method, (10 days)
  • 0306 DiGeorge Syndrome (from 31 MS Panel), (10 days)
  • 0115.1 DiGeorge Syndrome. FISH Method, (10 days)
  • 0115.9 Edwards Syndrome (Trisomy 18). FISH Method, (10 days)
  • 0115.5 Kallmann Syndrome (X-linked Ichthyosis). FISH Method, (11 days)
  • 0301 Cri-du-chat Syndrome (from 31 MS Panel), (10 days)
  • 0305 Langer-Giedion Syndrome (from 31 MS Panel), (10 days)
  • 0400 Martin-Bell Syndrome. Fragile X Syndrome (FRAX), (10 days)
  • 0302 Miller-Dieker Syndrome (from 31 MS Panel), (10 days)
  • 0115.8 Patau Syndrome (Trisomy 13) / Down Syndrome (Trisomy 21). FISH Method, (10 days)
  • 0116 Nijmegen Breakage Syndrome, (10 days)
  • 0309 Prader-Willi Syndrome (from 31 MS Panel), (10 days)
  • 0318 Prader-Willi Syndrome. Methylation Analysis, (10 days)
  • 0115.3 Prader-Willi Syndrome. FISH Method, (10 days)
  • 0312 Russell-Silver Syndrome, (10 days)
  • 0316 Rett Syndrome, (10 days)
  • 0304 Rubinstein-Taybi Syndrome (from 31 MS Panel), (10 days)
  • 0312 Silver-Russell Syndrome, (10 days)
  • 0303 Smith-Magenis Syndrome (from 31 MS Panel), (10 days)
  • 0310 Sotos Syndrome (from 31 MS Panel), (10 days)
Karyotyping
  • 0201 Peripheral Blood Lymphocyte Karyotyping (GTG-banding) without chromosome imaging, (15 days)
  • 0202 Peripheral Blood Lymphocyte Karyotyping (GTG-banding) with chromosome imaging, (20 days)
  • 0203 Peripheral Blood Lymphocyte Karyotyping (GTG-banding) with chromosome imaging for couples, (20 days)
  • 0204 Peripheral Blood Lymphocyte Karyotyping (GTG-banding) with chromosome imaging, Urgent, (12 days)
  • 0205 Oncohematological Diseases. Bone Marrow Karyotyping (GTG-banding), (15 days)
  • 0205.1 Oncohematological Diseases. Peripheral Blood Karyotyping (GTG-banding), (15 days)
Gastrointestinal Tract
  • 0051 Lactose Intolerance, (2 days)
  • 0059 Crohn’s Disease, (6 days)
  • 0071 Genetic Factors of Pancreatitis, (6 days)
  • 0071.1 Genetic Factors of Pancreatitis (SPINK1), (6 days)
  • 0352 Shwachman-Diamond Syndrome Diagnostics (SBDS, Exon 2 sequencing) 
  • 0352.1 Shwachman-Diamond Syndrome Diagnostics (SBDS, Exons 1, 3, 4, 5 sequencing)
Cardiovascular Genetics
  • 0076 Hereditary Thrombophilic Factors, (6 days)
  • 0076.1 Factor V Leiden (FVL) Mutation, (6 days)
  • 0076.2 Prothrombin G20210A (Factor II) Mutation, (6 days)
  • 0077 (0104) Hereditary Thrombophilic Factors. Recurrent Pregnancy Loss, (6 days)
  • 0078 Hereditary Thrombophilic Factors. Expanded Panel, (6 days)
  • 0080 Warfarin Sensitivity/Dosing, (6 days)
  • 0117 Angiotensin-Converting Enzyme (ACE) Gene, (6 days)
Enzymopathies
  • 0090 Galactosemia, (7 days)
  • 0086 Phenylketonuria, (10 days)
  • 0086.1 Phenylketonuria (Extended Panel for Children), (10 days)
Neurological and Neuromuscular Disorders
  • 0062 APOE Genotyping (Apolipoprotein E). Risk of Alzheimer’s Disease, (6 days)
  • 0084 Spinal Muscular Atrophy (SMA), (8 days)
  • 0084.1 SMA Carrier Screening, (8 days)
  • 0084.2 Spinal Muscular Atrophy (SMA). SMN Gene Copy Number Analysis, (10 days)
  • 0088 Duchenne/Becker Muscular Dystrophy, (10 days)
  • 0088.1 Duchenne/Becker Muscular Dystrophy. MLPA, (12 days)
  • 0119 Kennedy Disease (Spinal Bulbar Muscular Atrophy), (7 days)
  • 0137 Spinocerebellar Ataxia (SCA), Repeat Expansion Analysis in SCA1, SCA3, and SCA7 Genes, (12 days)
  • 0320 Autism Panel 1. Detection of Deletions/Duplications in Chromosomal Regions 15q11-q13 (UBE3A, GABRB3, CHRNA7), 16p11.2, and 22q13 (SHANK3), (10 days)
HLA Typing and Transplantation
  • 0098 HLA Class II Genotyping: DQA1 and DRB1 Loci, (12 days)
  • 0099 HLA Class II Genotyping: DRB1, DQA1, and DQB1 Loci, (12 days)
  • 0100 HLA Class II Genotyping: DQB1 Locus, (6 days)
  • 0101 HLA Typing Classes I and II (Major Histocompatibility Complex): HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB345, (7 days)
Immunodeficiency Disorders
  • 0116 Nijmegen Breakage Syndrome, (10 days)
  • 0123 Immunodeficiency States (TREC and KREC Quantification), (5 days)
  • 0352 Shwachman-Diamond Syndrome Diagnosis (SBDS Gene, Exon 2 Sequencing)
  • 0352.1 Shwachman-Diamond Syndrome Diagnosis (SBDS Gene, Exons 1, 3, 4, 5 Sequencing)
Prenatal Diagnosis
  • 0112.1 FISH Method (Prenatal Panel). Aneuploidy Screening for Chromosomes 13, 18, 21, X, and Y, (12 days)
  • 0314 31 Microdeletion Syndromes. MULTI Microdeletion Syndromes Panel, (10 days)
  • 0315 ALL-chromosome. Subtelomeric Regions Detection for All Chromosomes, (10 days)
  • 0317 Adrenogenital Syndrome (Congenital Adrenal Hyperplasia). MLPA, (10 days)
  • 0311 Angelman Syndrome (from 31 MS Panel), (10 days)
  • 0319 Angelman Syndrome. Methylation Analysis, (10 days)
  • 0115.4 Angelman Syndrome. FISH Method, (10 days)
  • 0115.6 X-Chromosome Copy Number Analysis, (10 days)
  • 0313 Beckwith-Wiedemann Syndrome, (10 days)
  • 0308 Williams Syndrome (from 31 MS Panel), (10 days)
  • 0303 Smith-Magenis Syndrome (from 31 MS Panel), (10 days)
  • 0310 Sotos Syndrome (from 31 MS Panel), (10 days)
  • 0115.7 Williams Syndrome (Williams-Beuren). FISH Method, (10 days)
  • 0307 Wolf-Hirschhorn Syndrome (from 31 MS Panel), (10 days)
  • 0115.2 Wolf-Hirschhorn Syndrome. FISH Method, (10 days)
  • 0115.8 Down Syndrome (Trisomy 21) / Patau Syndrome (Trisomy 13). FISH Method, (10 days)
  • 0306 DiGeorge Syndrome (from 31 MS Panel), (10 days)
  • 0115.1 DiGeorge Syndrome. FISH Method, (10 days)
  • 0115.9 Edwards Syndrome (Trisomy 18). FISH Method, (10 days)
  • 0115.5 Kallmann Syndrome (X-linked Ichthyosis). FISH Method, (11 days)
  • 0301 Cri-du-chat Syndrome (from 31 MS Panel), (10 days)
  • 0305 Langer-Giedion Syndrome (from 31 MS Panel), (10 days)
  • 0302 Miller-Dieker Syndrome (from 31 MS Panel), (10 days)
  • 0309 Prader-Willi Syndrome (from 31 MS Panel), (10 days)
  • 0318 Prader-Willi Syndrome. Methylation Analysis, (10 days)
  • 0115.3 Prader-Willi Syndrome. FISH Method, (10 days)
  • 0312 Silver-Russell Syndrome, (10 days)
  • 0316 Rett Syndrome, (10 days)
  • 0304 Rubinstein-Taybi Syndrome (from 31 MS Panel), (10 days)
Kinship (Relatedness) Testing and DNA Profiling
  • 0500 Kinship Testing, 16 Loci (2 persons), (6 days)
  • 0501 Kinship Testing, 16 Loci (3 persons), (6 days)
  • 0502 Kinship Testing, 25 Loci (2 persons), (6 days)
  • 0503 Kinship Testing, 25 Loci (3 persons), (6 days)
  • 0504 Genetic Profiling, 16 Loci (1 person), (6 days)
  • 0505 Genetic Profiling, 25 Loci (1 person), (6 days)
Real-Time PCR Pathogen Detection
  • 052.SARS-CoV-2 Virus. Detection of SARS-CoV-2 RNA, (1 day)
  • 046.Hepatitis B Virus (HBV), Qualitative, (2 days)
  • 047.Hepatitis B Virus (HBV), Quantitative, (2 days)
  • 048.Hepatitis C Virus (HCV), Qualitative, (2 days)
  • 049.Hepatitis C Virus (HCV), Quantitative, (2 days)
  • 050.Hepatitis C Virus (HCV). RNA Genotyping (1b, 1, 2, 3, 4, 5, 6), (2 days)
  • Hepatitis D Virus (HDV), Qualitative, (2 days)
NGS (Next-Generation Sequencing)
  • Exome UA – Whole Exome Sequencing (WES) via NGS, (3 months)
  • Ataxia-Telangiectasia Diagnosis. ATM Gene Sequencing via NGS, (3 months)
  • Cystic Fibrosis Diagnosis. CFTR Gene Sequencing via NGS, (3 months)
  • Osteogenesis Imperfecta Diagnosis (OMIM 166200). COL1A1 / COL1A2 Gene Sequencing via NGS, (3 months)
  • Polycystic Kidney Disease Diagnosis (OMIM 173900). PKD1 Gene Sequencing via NGS, (3 months)
  • Brugada Syndrome Diagnosis. SCN5A Gene Sequencing via NGS, (3 months)
  • Emery-Dreifuss Muscular Dystrophy Diagnosis. LMNA Gene Sequencing via NGS, (3 months)
  • Kabuki Syndrome Diagnosis. KMT2D and KDM6A Gene Sequencing via NGS, (3 months)
  • Lynch Syndrome Diagnosis via NGS, (3 months)
  • Marfan Syndrome and Fibrillin-Associated States Diagnosis (OMIM 134797). FBN1 Gene Sequencing via NGS, (3 months)
  • Netherton Syndrome Diagnosis. SPINK5 Gene Sequencing via NGS, (3 months)
  • Familial Adenomatous Polyposis and Colorectal Cancer Diagnosis. APC Gene Sequencing via NGS, (3 months)
  • Tuberous Sclerosis Diagnosis. TSC1 / TSC2 Gene Sequencing via NGS, (3 months)
  • Phenylketonuria (PKU) Diagnosis. PAH Gene Sequencing via NGS, (3 months)
  • Wilson’s Disease Diagnosis. ATP7B Gene Sequencing via NGS, (3 months)
  • Neurofibromatosis Type 1 (OMIM 162200). NF1 Gene Sequencing via NGS, (3 months)
  • Oncology Panel Diagnosis (BRCA1, BRCA2, APC, MLH1, MSH2, MSH6, PMS2, TP53, NBN, CHEK2, FH, PTEN, EPCAM) via NGS, (3 months)
  • Predictive Genetic Testing via NGS, (3 months)
  • Hereditary Angioedema (HAE) Diagnosis (OMIM 106100), Types 1-3. F12, ANGPT1, PLG, KNG1, MYOF, and HS3ST Gene Sequencing via NGS, (3 months)
  • BRCA1 and BRCA2 Gene Sequencing via NGS, (3 months)
  • Rett Syndrome. MECP2 Gene Sequencing via NGS, (3 months)
  • Familial Hypercholesterolemia Diagnosis (OMIM 606945). LDLR, APOB, and PCSK9 Gene Sequencing via NGS, (3 months)

Advanced Genetic Research and Diagnostics in Lviv

The Leogene Scientific Medical and Diagnostic Center in Lviv specializes in cutting-edge molecular genetic and cytogenetic research.

Our core diagnostic capabilities include:

  • DNA Sequencing: A high-precision method that allows us to determine full genetic profiles and identify even the rarest genetic variations.
  • Chromosomal Analysis (Karyotyping): We utilize various methods to characterize the karyotype—analyzing both the structure and number of chromosomes.
  • FISH Analysis (Fluorescence In Situ Hybridization): This advanced technique allows for the precise localization of specific genetic sequences on chromosomes.
  • Genetic Pathology Screening: We offer testing for a wide range of hereditary disorders (such as Cystic Fibrosis and Phenylketonuria) as well as genetic risk factors, including Thrombophilia.